(Q58886172)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

randomized controlled trial

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Colin M Dayan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J. Hans DeVries

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

J Hermanides

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D Bruttomesso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Mathieu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Frid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

P Diem

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Fermon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

I M E Wentholt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J B L Hoekstra

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1158-1167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

The barrier of hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Continuous glucose monitors: the long-awaited watch dogs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Continuous glucose monitoring and intensive treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

SF-36 health survey update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Assessment of diabetes-related distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Fear of hypoglycemia: quantification, validation, and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Sense and nonsense in sensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

Hypoglycemia in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03256.X

10.1111/J.1464-5491.2011.03256.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21294770%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference